Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells

被引:44
作者
Hickling, TP
Malhotra, R
Bright, H
McDowell, W
Blair, ED
Sim, RB
机构
[1] Glaxo Wellcome Res & Dev Ltd, Cellular Biochem Unit, Med Res Ctr, Stevenage SG1 2NY, Herts, England
[2] Glaxo Wellcome Res & Dev Ltd, Syst Biol Unit, Med Res Ctr, Stevenage SG1 2NY, Herts, England
[3] Glaxo Wellcome Res & Dev Ltd, Virol Unit, Med Res Ctr, Stevenage SG1 2NY, Herts, England
[4] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England
关键词
D O I
10.1089/vim.2000.13.125
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lung surfactant protein A (SP-A) has a central role in host defense mediated by the interaction of surface carbohydrates of inhaled pathogens with the lectin domains of SP-A, Respiratory syncytial virus (RSV), the most important viral pathogen of neonates and infants, encodes a highly glycosylated attachment protein, G, Binding studies were performed with G-protein from RSV (human, A2 strain) and human SP-A, The effect of SP-A on the interaction between RSV and host cells was determined by two methods: an infectivity study with monolayers of Hep-2C cells and by interleukin-8 (IL-8) release from buffy coat (BC) cells. SP-A binds to RSV G-protein in a concentration-dependent manner that is inhibitable by both ethylenediamine tetraacetic acid (EDTA) and mannan, indicating that binding is through the carbohydrate recognition domain of the SP-A and a carbohydrate moiety of the G-protein, The level of RSV infection of Hep-2C cells increases with increasing concentrations of SP-A, The amount of IL-8 released by BC cells in the presence of RSV is increased with SP-A concentrations of 2.9 mu g/mL or greater. Our results show that SP-A enhances the attachment of RSV and subsequent entry into host cells. The effect of SP-A on viral uptake by epithelial cells and macrophage may determine both innate and adaptive immune responses to RSV.
引用
收藏
页码:125 / 135
页数:11
相关论文
共 54 条
[1]   ANTIGENIC CHARACTERIZATION OF RESPIRATORY SYNCYTIAL VIRUS-STRAINS WITH MONOCLONAL-ANTIBODIES [J].
ANDERSON, LJ ;
HIERHOLZER, JC ;
TSOU, C ;
HENDRY, RM ;
FERNIE, BF ;
STONE, Y ;
MCINTOSH, K .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (04) :626-633
[2]  
ARNOLD R, 1995, IMMUNOLOGY, V85, P364
[3]   Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin [J].
Bitko, V ;
Velazquez, A ;
Yang, L ;
Yang, YC ;
Barik, S .
VIROLOGY, 1997, 232 (02) :369-378
[4]  
Cane PA, 1996, J MED VIROL, V48, P253, DOI 10.1002/(SICI)1096-9071(199603)48:3<253::AID-JMV7>3.3.CO
[5]  
2-F
[6]   EFFECT OF SURFACTANT-ASSOCIATED PROTEIN-A (SP-A) ON THE ACTIVITY OF LIPID EXTRACT SURFACTANT [J].
CHUNG, J ;
YU, SH ;
WHITSETT, JA ;
HARDING, PGR ;
POSSMAYER, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1002 (03) :348-358
[7]   OLIGOMERIZATION AND POSTTRANSLATIONAL PROCESSING OF GLYCOPROTEIN-G OF HUMAN RESPIRATORY SYNCYTIAL VIRUS - ALTERED O-GLYCOSYLATION IN THE PRESENCE OF BREFELDIN-A [J].
COLLINS, PL ;
MOTTET, G .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :849-863
[8]   PULMONARY SURFACTANT AND ITS COMPONENTS INHIBIT SECRETION OF PHOSPHATIDYLCHOLINE FROM CULTURED RAT ALVEOLAR TYPE-II CELLS [J].
DOBBS, LG ;
WRIGHT, JR ;
HAWGOOD, S ;
GONZALEZ, R ;
VENSTROM, K ;
NELLENBOGEN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (04) :1010-1014
[9]   SURFACTANT PROTEIN-A PROMOTES ATTACHMENT OF MYCOBACTERIUM-TUBERCULOSIS TO ALVEOLAR MACROPHAGES DURING INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DOWNING, JF ;
PASULA, R ;
WRIGHT, JR ;
TWIGG, HL ;
MARTIN, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4848-4852
[10]   MONOCLONAL ANTIBODY-BASED CAPTURE ENZYME IMMUNOASSAYS FOR SPECIFIC SERUM IMMUNOGLOBULIN-G (IGG), IGA, AND IGM ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS [J].
ERDMAN, DD ;
ANDERSON, LJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (12) :2744-2749